Attention Deficit/Hyperactivity Disorder

Jan 1, 2013 Issue
AAP Releases Guideline on Diagnosis, Evaluation, and Treatment of ADHD [Practice Guidelines]

The American Academy of Pediatrics (AAP) first published guidelines on the diagnosis and evaluation of attention-deficit/hyperactivity disorder (ADHD) in 2000, with recommendations for treatment published in 2001. Based on new data collected since then, the AAP released new guidelines in 2011, which...

Sep 1, 2012 Issue
Amphetamines for Attention-Deficit/Hyperactivity Disorder in Adults [Cochrane for Clinicians]

Amphetamines improve ADHD symptom severity but, when compared with placebo, they are associated with increased discontinuation rates because of adverse effects. There does not appear to be a difference among dosages or between the immediate- and sustained-release formulations.

May 1, 2012 Issue
Diagnosis and Management of Attention-Deficit/Hyperactivity Disorder in Adults [Article]

Attention-deficit/hyperactivity disorder in childhood can persist into adulthood in at least 30 percent of patients, with 3 to 4 percent of adults meeting the Diagnostic and Statistical Manual of Mental Disorders, 4th ed., diagnostic criteria. A number of conditions, such as thyroid disease, mood di...

Mar 15, 2011 Issue
ICSI Releases Guideline on Diagnosis and Management of ADHD in Children [Practice Guidelines]

Attention-deficit/hyperactivity disorder (ADHD) is a common condition marked by inattention, hyperactivity, and impulsivity. The Institute for Clinical Systems Improvement (ICSI) has released guideline on diagnosis and management of ADHD in children.

Feb 15, 2011 Issue
Guanfacine (Intuniv) for Attention-Deficit/Hyperactivity Disorder [STEPS]

Guanfacine is an effective short-term treatment option for ADHD in children six to 12 years of age. Sedation is a marked problem in many children. Patients should take the medication daily to avoid adverse effects that occur with abrupt discontinuation or when the guanfacine is restarted.

May 15, 2009 Issue
AAP Responds to AHA Guidelines on Cardiovascular Monitoring Before Starting Stimulants for ADHD [Practice Guidelines]

A recent guideline from the American Heart Association (AHA) recommended routine electrocardiography (ECG) in children before they begin pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD). That recommendation contradicts evidence-based recommendations from the American Academy of Ch...

May 15, 2009 Issue
Stimulants, ADHD, and the Heart [Editorials]

Apr 15, 2009 Issue
Multimodal Treatment of Attention-Deficit/Hyperactivity Disorder in Children [Editorials]

Apr 15, 2009 Issue
Current Strategies in the Diagnosis and Treatment of Childhood Attention-Deficit/Hyperactivity Disorder [Article]

Symptoms of childhood attention-deficit/hyperactivity disorder affect cognitive, academic, behavioral, emotional, social, and developmental functioning. Attention-deficit/hyperactivity disorder is the most commonly diagnosed neurodevelopmental disorder in children and adolescents. An estimated 2 to ...

Feb 15, 2006 Issue
CDC Releases Data on ADHD Diagnosis and Treatment in Children [Practice Guidelines]

A report analyzing the rate of diagnosis and treatment of attention-deficit/hyperactivity disorder (ADHD) among children and adolescents has been released by the Centers for Disease Control and Prevention (CDC).

Pages: Previous 1 2 3 Next

Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now